Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
63 studies found for:    parkinson's disease AND baylor
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Unknown  MER Versus MRI Guidance DBS in Parkinson's Disease
Condition: Idiopathic Parkinson's Disease (PD)
Intervention:
2 Completed
Has Results
Amitiza in Constipation Associated With PD (Parkinson's Disease)
Condition: Parkinson's Disease
Intervention: Drug: LUBIPROSTONE
3 Completed Trial of Xyrem for Excessive Daytime Sleepiness and Sleep Disturbance in Parkinson's Disease (PD)
Condition: Parkinson Disease
Intervention: Drug: sodium oxybate
4 Completed Namenda (Memantine) for Non-Motor Symptoms in Parkinson's Disease
Condition: Parkinson's Disease
Interventions: Drug: Memantine;   Drug: placebo
5 Withdrawn Acamprosate for Treatment of Compulsive Behaviors and Craving in Parkinson's Disease
Condition: Parkinson's Disease
Intervention: Drug: acamprosate
6 Completed Tolerability and Efficacy of Switch From Oral Selegiline to Orally Disintegrating Selegiline (Zelapar) in Patients With Parkinson's Disease
Condition: Parkinson's Disease
Intervention: Drug: Zelapar
7 Completed Parcopa Versus Carbidopa-Levodopa in a Single Dose Cross-Over Comparison Study
Condition: Parkinson's Disease
Interventions: Drug: Parcopa;   Drug: carbidopa-levodopa
8 Active, not recruiting A Pilot Study of Deep Brain Stimulation to the Lateral Habenulae in Treatment-Resistant Depression
Condition: Treatment Resistant Major Depressive Disorder
Intervention: Device: Medtronic Activa Tremor Control System
9 Completed Flu-Like Symptoms as a Complication of Botulinum Toxin Therapy
Condition: Flu-like Symptoms
Intervention:
10 Recruiting Mobile Decision Support System for Nurse Management of Neuromodulation Therapy
Condition: Parkinson's Disease
Interventions: Device: iPad-Based Clinical Support Care;   Other: Standard Clinical Care
11 Completed Multicenter Study of Rasagiline in Parkinson's Disease Patients Using Levodopa and Experiencing Motor Fluctuations
Condition: Parkinson's Disease
Interventions: Drug: rasagiline mesylate;   Drug: 1.0 mg rasagiline mesylate;   Other: Placebo
12 Recruiting Study of Urate Elevation in Parkinson's Disease, Phase 3
Condition: Parkinson's Disease
Interventions: Drug: Inosine;   Drug: Placebo
13 Recruiting OHI--Randomized Control Trial to Evaluate Efficacy, Acceptability, and Perception of Benefit of an Innovative Custom AFO
Conditions: Accidental Falls;   Fall Due to Loss of Equilibrium;   High Risk of Falls Due to Mobility Limitation;   Diabetes;   Arthritis;   Cancer;   Peripheral Arterial Disease;   Parkinson's Disease;   End Stage Renal Failure on Dialysis
Interventions: Device: AFO;   Other: Control
14 Not yet recruiting A Study to Evaluate the Efficacy of RO7046015 in Participants With Early Parkinson's Disease
Condition: Parkinson's Disease
Interventions: Drug: RO7046015;   Drug: Placebo
15 Completed
Has Results
Connect.Parkinson: Connecting Individuals With Parkinson Disease to Specialists in Their Homes
Condition: Parkinson Disease
Intervention: Other: Virtual Visits
16 Recruiting Efficacy, Safety and Tolerability of PF-06649751 in Parkinson's Disease Patients at Early Stage of the Disease
Condition: Parkinson Disease
Interventions: Drug: Placebo;   Drug: PF-06649751
17 Recruiting SYN120 a Dual 5-HT6/5-HT2A Antagonist Proof of Concept Study to Evaluate Its Safety, Tolerability and Efficacy in Parkinson's Disease Dementia (SYNAPSE)
Condition: Parkinson's Disease Dementia (PDD)
Interventions: Drug: SYN120;   Drug: Placebo
18 Completed Investigation of Cogane (PYM50028) in Early-stage Parkinson's Disease (CONFIDENT-PD)
Condition: Parkinson's Disease
Interventions: Drug: PYM50028;   Drug: Placebo
19 Recruiting Efficacy, Safety and Tolerability of PF-06649751 in Parkinson's Disease Patients With Motor Fluctuations
Condition: Parkinson Disease
Interventions: Drug: Placebo;   Drug: PF-06649751 low dose (1 mg QD);   Drug: PF-06649751 middle dose 1 (3 mg QD);   Drug: PF-06649751 middle dose 2 (7 mg QD);   Drug: PF-06649751 high dose (15 mg QD)
20 Completed
Has Results
An Open Label Extension Study of the Safety and Clinical Utility of IPX066 in Subjects With Parkinson's Disease
Condition: Parkinson's Disease
Interventions: Drug: IPX066 95 mg;   Drug: IPX066 145 mg;   Drug: IPX066 195 mg;   Drug: IPX066 245 mg

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.